ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0339

Clinical Characteristics Associated with Inpatient Mortality in Dermatomyositis Patients: A Single Center Retrospective Cohort Study

Anjana Srikumar, Keon Niknejad, Maria Kaltchenko and Jun Kang, Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: ACR Convergence 2024

Keywords: dermatomyositis, interstitial lung disease, Mortality

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 16, 2024

Title: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Dermatomyositis (DM) is a rare autoimmune disease associated with higher rates of hospitalization, longer lengths of stay, higher mean hospitalization costs, and increased inpatient mortality. However, current studies investigating DM inpatient stays have used larger population-based datasets and have not assessed the underlying, patient-level factors that may contribute to worse inpatient outcomes – a gap that we aim to address in this study.

Methods: We conducted a retrospective chart review of 148 DM patients admitted to Johns Hopkins Hospital between October 2013 and February 2024. Demographic and clinical characteristics were analyzed using chi-squared tests, t-tests, and adjusted logistic regression modeling to identify factors associated with mortality.

Results: Out of 148 patients, 16 (10.8%) died during hospitalization. Compared to survivors, patients who died had a shorter duration of active DM before admission (4.08 vs. 7.57 years, p=0.023) and were more likely to have primary admission diagnoses involving respiratory complications (43.8% vs. 15.9%, p=0.019) or infections (18.8 vs 5.3%, p=0.135). Patients with pre-existing interstitial lung disease (ILD) were more likely to die (p< .01, OR 8.50, 95% CI 1.99-36.33) than patients without ILD. Infection (p< .01), bacteremia (p< .01), deep vein thrombosis/pulmonary embolism (DVT/PE) (p< .01), and respiratory failure (p< .001) were significantly associated with in-hospital mortality. Notably, every patient who died experienced respiratory failure during admission. Neither cancer nor the type of dermatomyositis (classic vs. clinically amyopathic) impacted mortality.

Conclusion: Pre-existing ILD and in-hospital adverse events, particularly respiratory failure, are significant predictors of inpatient mortality in DM patients. Clinicians should prioritize early identification and management of these risk factors to improve hospital outcomes in this population.

Supporting image 1

Supporting image 2

Supporting image 3

Odds ratios, adjusted for age, race, sex, ethnicity, insurance, and smoking status.


Disclosures: A. Srikumar: None; K. Niknejad: None; M. Kaltchenko: None; J. Kang: None.

To cite this abstract in AMA style:

Srikumar A, Niknejad K, Kaltchenko M, Kang J. Clinical Characteristics Associated with Inpatient Mortality in Dermatomyositis Patients: A Single Center Retrospective Cohort Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/clinical-characteristics-associated-with-inpatient-mortality-in-dermatomyositis-patients-a-single-center-retrospective-cohort-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-associated-with-inpatient-mortality-in-dermatomyositis-patients-a-single-center-retrospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology